Citigroup’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.18K | Buy |
+1,028
| New | +$10.2K | ﹤0.01% | 5073 |
|
|
2025
Q3 | – | Hold |
0
| – | -$1 | – | 6285 |
|
|
2025
Q2 | – | Sell |
-1,758
| Closed | -$17.9K | – | 5618 |
|
|
2025
Q1 | $19.9K | Buy |
+1,758
| New | +$31.9K | ﹤0.01% | 5094 |
|
|
2024
Q4 | – | Sell |
-5
| Closed | -$195 | – | 5928 |
|
|
2024
Q3 | $195 | Buy |
+5
| New | +$135 | ﹤0.01% | 5514 |
|
|
2022
Q2 | – | Sell |
-5
| Closed | – | – | 6592 |
|
|
2022
Q1 | $0 | Buy |
+5
| New | +$212 | ﹤0.01% | 6559 |
|
|
2021
Q2 | – | Sell |
-42
| Closed | -$5K | – | 6360 |
|
|
2021
Q1 | $5K | Sell |
42
-82
| -66% | -$12.1K | ﹤0.01% | 5904 |
|
|
2020
Q4 | $14K | Buy |
124
+94
| +313% | +$10.5K | ﹤0.01% | 6838 |
|
|
2020
Q3 | $4K | Sell |
30
-56
| -65% | -$9.69K | ﹤0.01% | 7143 |
|
|
2020
Q2 | $18K | Sell |
86
-82
| -49% | -$19.4K | ﹤0.01% | 6707 |
|
|
2020
Q1 | $38K | Buy |
168
+55
| +49% | +$15.7K | ﹤0.01% | 6231 |
|
|
2019
Q4 | $30K | Sell |
113
-70
| -38% | -$17.6K | ﹤0.01% | 6718 |
|
|
2019
Q3 | $55K | Sell |
183
-97
| -35% | -$29.8K | ﹤0.01% | 6069 |
|
|
2019
Q2 | $93K | Sell |
280
-13
| -4% | -$6.6K | ﹤0.01% | 5943 |
|
|
2019
Q1 | $184K | Sell |
293
-104
| -26% | -$47.4K | ﹤0.01% | 5192 |
|
|
2018
Q4 | $99K | Buy |
397
+89
| +29% | +$35.4K | ﹤0.01% | 5663 |
|
|
2018
Q3 | $143K | Sell |
308
-69
| -18% | -$33.4K | ﹤0.01% | 5557 |
|
|
2018
Q2 | $205K | Buy |
377
+286
| +314% | +$172K | ﹤0.01% | 5048 |
|
|
2018
Q1 | $52K | Buy |
91
+2
| +2% | +$1.26K | ﹤0.01% | 6139 |
|
|
2017
Q4 | $57K | Buy |
89
+14
| +19% | +$9.86K | ﹤0.01% | 6086 |
|
|
2017
Q3 | $71K | Buy |
75
+72
| +2,400% | +$55.1K | ﹤0.01% | 5804 |
|
|
2017
Q2 | $3K | Sell |
3
-38
| -93% | -$31.1K | ﹤0.01% | 6899 |
|
|
2017
Q1 | $29K | Sell |
41
-340
| -89% | -$224K | ﹤0.01% | 6063 |
|
|
2016
Q4 | $275K | Buy |
381
+274
| +256% | +$189K | ﹤0.01% | 5017 |
|
|
2016
Q3 | $79K | Buy |
107
+19
| +22% | +$15.4K | ﹤0.01% | 5363 |
|
|
2016
Q2 | $74K | Sell |
88
-316
| -78% | -$294K | ﹤0.01% | 5324 |
|
|
2016
Q1 | $334K | Buy |
404
+375
| +1,293% | +$295K | ﹤0.01% | 4580 |
|
|
2015
Q4 | $33K | Buy |
29
+3
| +12% | +$3.49K | ﹤0.01% | 6216 |
|
|
2015
Q3 | $21K | Sell |
26
-13
| -33% | -$18.8K | ﹤0.01% | 6006 |
|
|
2015
Q2 | $69K | Buy |
39
+13
| +50% | +$16.5K | ﹤0.01% | 5283 |
|
|
2015
Q1 | $31K | Sell |
26
-143
| -85% | -$167K | ﹤0.01% | 5823 |
|
|
2014
Q4 | $191K | Buy |
169
+151
| +839% | +$155K | ﹤0.01% | 4732 |
|
|
2014
Q3 | $18K | Buy |
18
+6
| +50% | +$6.78K | ﹤0.01% | 5968 |
|
|
2014
Q2 | $15K | Sell |
12
-45
| -79% | -$54.1K | ﹤0.01% | 5968 |
|
|
2014
Q1 | $80K | Sell |
57
-423
| -88% | -$550K | ﹤0.01% | 5183 |
|
|
2013
Q4 | $551K | Sell |
480
-104
| -18% | -$143K | ﹤0.01% | 3704 |
|
|
2013
Q3 | $733K | Buy |
584
+454
| +349% | +$308K | ﹤0.01% | 3133 |
|
|
2013
Q2 | $52K | Buy |
+130
| New | +$55.1K | ﹤0.01% | 5365 |
|
Other funds holding RMTI
VCM
VFT
WANY
Citigroup's RMTI Position: Q1 2026 in Review
Citigroup opened a new position in Rockwell Medical (RMTI) in Q1 2026: 1,028 shares worth $9.18K. The stake represents ﹤0.01% of the portfolio and ranks #5073 among its holdings. This is a return to the name: Citigroup previously reported a position in RMTI as recently as Q1 2025.
Citigroup first reported a position in RMTI in Q2 2013 and has held it in 36 quarters since. The position peaked at $733K in Q3 2013. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.
- Citigroup held 1,028 shares of Rockwell Medical worth $9.18K as of Q1 2026.
- Rockwell Medical was a new Citigroup position in Q1 2026.
- Rockwell Medical made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5073 holding.
- Citigroup first reported a position in Rockwell Medical in Q2 2013 and has held it in 36 quarters since.
- Citigroup's Rockwell Medical position peaked at $733K in Q3 2013.
- 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.